Identification of endogenous morphine and a μ3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy

Medical Science Monitor

Volumn 14, Issue 6, 2008, Pages

  Fricchione, Gregory ^a   Zhu, Wei ^b   Cadet, Patrick ^b   Mantione, Kirk J ^b   Bromfield, Edward ^a   Madsen, Joseph ^c   DeGirolami, Umberto ^c   Dworetzky, Barbara ^a   Vaccaro, Bernardino ^c   Black, Peter ^c   Stefano, George B ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

3 like opiate receptor; Endogenous morphine; Epilepsy; Morphine; Mu opiate receptors (MORs); Temporal lobe

Indexed keywords

CEFAZOLIN; DEXAMETHASONE; DEXMEDETOMIDINE; ETIRACETAM; FENTANYL; FUROSEMIDE; MANNITOL; MIDAZOLAM; MORPHINE; MU 3 LIKE OPIATE RECEPTOR; MU OPIATE RECEPTOR; MULTIVITAMIN; OXCARBAZEPINE; PROPOFOL; RECEPTOR SUBTYPE; RNA; SUFENTANIL; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BRAIN TISSUE; CASE REPORT; COMPLEX PARTIAL SEIZURE; ELECTROCORTICOGRAPHY; FOCAL EPILEPSY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRACTABLE EPILEPSY; MALE; RADIOIMMUNOASSAY; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY;

ADULT; BASE SEQUENCE; BRAIN; ELECTROPHORESIS, AGAR GEL; EPILEPSY, COMPLEX PARTIAL; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MORPHINE; POLYMERASE CHAIN REACTION; RECEPTORS, OPIOID, MU;

EID: 46449093151     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kream RM, Stefano GB: De novo biosynthesis of morphine in animal cells: An evidence-based model. Med Sci Monit, 2006; 12(10): RA207-19
2. Cadet P, Mantione KJ, Zhu W et al: A functionally coupled mu 3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J Immunol, 2007; 179: 5839-44
3. Muller A, Glattard E, Taleb O et al: Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PloS ONE. Last updated: 2008 Feb [cited www.plosone.org/doi/pone.0001641
4. Zhu W, Mantione KJ, Shen L et al: Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit, 2005; 11(11): BR397-404.
5. Zhu W, Cadet P, Baggerman G et al: Human white blood cells synthesize morphine: CYP2D6 modulation. J Immunol, 2005; 175: 7357-62
6. Homayoun H, Khavandgar S, Namiranian K et al: The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res, 2002; 48: 33-41
7. Riazi K, Honar H, Homayoun H et al: The synergistic anticonvulsant effect of agmatine and morphine: possible role of alpha 2-adrenoceptors. Epilepsy Res, 2005; 65: 33-40
8. Spector S, Munjal I, Schmidt DE: Endogenous morphine and codeine. Possible role as endogenous anticonvulsants. Brain Res, 2001; 915: 155-60
9. Zhu W, Ma Y, Bell A et al: Presence of morphine in rat amygdala: Evidence for the mu? opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit, 2004; 10(12): BR433-39
10. Goumon Y, Stefano GE: Identification of morphine in the rat adrenal gland. Mol Brain Res, 2000; 77: 267-69
11. Cadet P, Mantione KJ, Stefano GB: Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol, 2003; 170: 5118-23
12. Cadet P: Nitric oxide modulates the physiological control of ciliary activity in the marine mussel Mytilus edulis via morphine: Novel mu opiate receptor splice variants. Neuroendocrinology Letters, 2004; 25: 184-90
13. Kream RM, Sheehan M, Cadet P et al: Persistence of evolutionary memory: Primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling. Med Sci Monit, 2007; 13(12): SC5-SC6
14. Stefano GB, Scharrer B: Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol, 1994; 4: 57-68
15. Atapour N, Kalantaripour TP, Nourpanah M, Niazi M: Chemical kindling and seizure susceptibility in morphine dependent rats. Eur Neuropsychopharmacol, 2000; 10: 483-87
16. Stefano GB, Hartman A, Bilfinger TV et al: Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem, 1995; 270: 30290-93
17. Honar H, Riazi K, Homayoun H et al: Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures. Neuroscience, 2004; 129: 733-42
18. Liao D, Lin H, Law PY, Loh HH: Mu-opioid receptors modulate the stability of dendritic spines. Proc Natl Acad Sci USA, 2005; 102: 1725-30
19. Arvidsson U, Riedl M, Chakrabarti S et al: Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci, 1995; 15: 3328-41
20. Wimpey TL, Chavkin C: Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron, 1991; 6: 281-89